Patient Capital Management
- Company typePrivate
- Founded2020
- HeadquartersBaltimore, United States
- Headcount1–10
- GTM typeB2B and B2C
- OfferingServices
Patient Capital Management firmographics
Firmographics- Name
- Patient Capital Management
- Legal name
- Patient Capital Management
- Website
- https://patientcapitalmanagement.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Patient Capital Management industry classification
Industry- Product category
- Asset Management
- NAICS
- Open-End Investment Funds (52591), Portfolio Management and Investment Advice (523940)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Target-Risk / Risk-Managed Allocation Funds (FSAAAEAG)
- akta.pro secondary industry
- Large-Cap Equity (Active) (FSAAAIAA)
Keywords
Where Patient Capital Management is headquartered
LocationHeadquarters
- HQ city
- Baltimore
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Patient Capital Management business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Asset Management Fees: The firm manages the Patient Opportunity Trust mutual fund with AUM of $1.86B (as of 12/31/2025). Revenue is generated through management fees based on assets under management across multiple share classes (Class A, C, FI, I, R, IS). Expense ratios range from 1.77% (Class IS) to 2.87% (Class C) on net basis.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Class A - Retail with front-end load |
| Subscription | Annual | Class C - Retail with deferred sales charge |
| Subscription | Annual | Class FI - Fee-based advisory shares |
| Subscription | Annual | Class I - Institutional investor shares |
| Subscription | Annual | Class R - Retirement plan shares |
| Subscription | Annual | Class IS - Institutional share class |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
Patient Capital Management product offering
Product offeringCore offering
Patient Capital Management manages the Patient Opportunity Trust, a flexible value mutual fund benchmarked against the S&P 500 with $1.86B AUM as of 12/31/2025. The firm implements a long-term, intrinsic value, behaviorally-focused investment approach across seven share classes (Class A, C, FI, I, R, IS) for individual investors, IRAs, 401K plans/rollovers, and institutional accounts including pension plans, foundations, and endowments.
Product overview
Patient Capital Management offers a single core investment product: the Patient Opportunity Trust, a flexible value fund with a contrarian bent. Celebrating 20 years of operation, the fund implements a long-term, intrinsic value, behaviorally-focused investment approach developed originally under Bill Miller at Legg Mason and continued by founder Samantha McLemore, CFA. The fund is managed for individual investors, institutional investors (pension plans, foundations, endowments), and retirement accounts (IRAs, 401K plans/rollovers).
Differentiator
Problem solved
Functional benefit
Brands
- Patient Opportunity Trust: The firm's flagship flexible value fund with a contrarian bent, celebrating 20 years focused on high returns. AUM of $1.86B as of 12/31/2025. Benchmark: S&P 500. Portfolio manager: Samantha McLemore, CFA.
Products and services
- Patient Opportunity Trust A flexible, value-focused mutual fund with a contrarian investment approach targeting long-term capital growth. The fund is benchmarked against the S&P 500 and offers seven share classes (LGOAX/LMOPX/LMOFX/LMNOX/LMORX/MVISX and additional classes) for individual investors (brokerage, IRAs), 401K plans/rollovers, and institutional accounts. Managed by Samantha McLemore, CFA, with $1.86B AUM as of 12/31/2025 and 94.64% active share.
Quantifiable outcome
- 17.88% annualized returns since March 2009 secular bull market inception, 153 bps per year better than S&P 500
- +3 more outcomes
Companies that use Patient Capital Management
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles2 records
Patient Capital Management technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Patient Capital Management partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Quasar Distributors, LLCcoreQuasar Distributors, LLC serves as the registered investment company distributor for Patient Opportunity Trust mutual fund, enabling distribution across multiple share classes to retail and institutional investors through standard investment channels.
Scale indicators6 records
Recent moves6 records
Expansion highlights4 records
Patient Capital Management competitors and assessment
Company assessmentDirect peers
- Tweedy, Browne Company: Tweedy, Browne is a long-tenured, value-oriented, concentrated mutual fund manager with high active share and a similarly contrarian, deep-fundamentals approach. Like Patient Capital, it sells primarily through mutual fund vehicles to individual and institutional clients and competes for value-oriented allocations.
- Longleaf Partners (Southeastern Asset Management): Longleaf Partners runs concentrated, high-active-share, value-tilted equity mutual funds benchmarked against the S&P 500 and other indices, with a long-term, behavioral-finance-aware philosophy. It is one of the closest public comparables in mandate, philosophy, and distribution mix.
- Dodge & Cox: Dodge & Cox is a San Francisco-based, value-driven mutual fund manager with concentrated portfolios across U.S. and international equities, distributed via institutional and retail share classes. Patient Capital competes head-to-head for the same long-term value-seeking institutional dollars.
- Oakmark Funds (Harris Associates): Oakmark Funds run concentrated, deep-value equity strategies with high active share and a long-tenured manager culture, distributed across multiple share classes including institutional and retirement channels. Both firms target the same patient, value-oriented investor base.
- Vulcan Value Partners: Vulcan Value Partners is a concentrated, value-tilted equity manager with a long-term intrinsic-value philosophy and high active share, structurally very similar to Patient Capital. Both emphasize behavioral mispricing and compete for institutional value mandates.
- Third Avenue Management: Third Avenue runs concentrated, deep-value mutual funds with a contrarian, fundamentals-first philosophy and multiple share classes. It is a closely comparable active value mutual fund competitor with similar distribution model.
- Miller Value Partners: Miller Value Partners is the predecessor firm from which Patient Capital spun out in 2020; it still runs Miller-style value strategies with high active share. The two share DNA, philosophy, and target investor base, and compete directly for the same legacy client relationships.
Broad incumbents
- First Eagle Investment Management: First Eagle is a larger, established value-oriented mutual fund manager (e.g., First Eagle Global, Gold funds) with a similarly patient, long-term, intrinsic-value approach. It competes for the same institutional and retail value allocations from a much larger scale and broader product line.
- T. Rowe Price: T. Rowe Price is a global asset management incumbent offering multi-cap value funds and institutional management that overlap with Patient Capital's offerings. While its scale, product breadth, and distribution dwarf Patient Capital's, it competes for the same retirement plan and institutional value allocations.
- Franklin Templeton: Franklin Templeton is a global asset manager (now including legacy Legg Mason funds) with a broad suite of value equity mutual funds and institutional strategies, distributed through wirehouses, retirement platforms, and institutional consultants. Patient Capital's strategy and Bill Miller lineage are directly comparable to one slice of Franklin Templeton's value franchise.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Patient Capital Management social profiles
Digital presencePatient Capital Management financial estimates
Financial estimateRevenue estimate
Valuation estimate
Patient Capital Management leadership team
Management profileNumber of profiles
Profiles6 records
Patient Capital Management funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Patient Capital Management M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Patient Capital Management
What does Patient Capital Management do?
Patient Capital Management manages the Patient Opportunity Trust, a flexible value mutual fund benchmarked against the S&P 500 with $1.86B AUM as of 12/31/2025. The firm implements a long-term, intrinsic value, behaviorally-focused investment approach across seven share classes (Class A, C, FI, I, R, IS) for individual investors, IRAs, 401K plans/rollovers, and institutional accounts including pension plans, foundations, and endowments.
Is Patient Capital Management a public or private company?
Patient Capital Management is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Patient Capital Management founded?
Patient Capital Management was founded in 2020. It employs 1 to 10 people.
Where is Patient Capital Management based?
Patient Capital Management is headquartered in Baltimore, United States, in the North America region.
How does Patient Capital Management make money?
One revenue line is on record: asset Management Fees.
Who are Patient Capital Management's main competitors?
Direct peers on record are Tweedy, Browne Company, Longleaf Partners (Southeastern Asset Management), Dodge & Cox, Oakmark Funds (Harris Associates), Vulcan Value Partners, Third Avenue Management and Miller Value Partners. Broad incumbents are First Eagle Investment Management, T. Rowe Price and Franklin Templeton.
Does Patient Capital Management have an API?
No public API is recorded for Patient Capital Management.
What industry is Patient Capital Management in?
Patient Capital Management's product category is Asset Management. Its primary akta.pro industry code is FSAAAEAG, Target-Risk / Risk-Managed Allocation Funds, with a secondary code of FSAAAIAA, Large-Cap Equity (Active). Its NAICS code is 52591 and its SIC code is 6282.